Evidence map›Paper›PMID 35051125›Full record

ReviewTropical medicine and infectious disease2022

SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review.

Caterina Ledda, Claudio Costantino, Giuseppe Motta, Rosario Cunsolo, Patrizia Stracquadanio, Giuseppe Liberti, Helena C Maltezou, Venerando Rapisarda

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. COVID-19: Current Status and Future Prospects.Tropical medicine and infectious disease · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caterina LeddaOccupational Medicine Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0003-0739-8798
Claudio CostantinoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, 90133 Palermo, Italy.ORCID 0000-0002-3397-7331
Giuseppe MottaOccupational Medicine Unit, "Garibaldi" Hospital of Catania, 95123 Catania, Italy.
Rosario CunsoloHospital Health Management, "G. Rodolico-San Marco" Polyclinic University Hospital, 95123 Catania, Italy.
Patrizia StracquadanioOccupational Medicine Unit, "G. Rodolico-San Marco" University Hospital, 95123 Catania, Italy.
Giuseppe LibertiCommissioner Office in Acta for the COVID-19 Emergency, Provincial Health Authority of Catania, 95123 Catania, Italy.
Helena C MaltezouDirectorate for Research, Studies and Documentation, National Public Health Organization, 15123 Athens, Greece.ORCID 0000-0003-0264-3547
Venerando RapisardaOccupational Medicine Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-3482-1136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of people vaccinated against COVID-19 increases worldwide every day; however, it is important to study the risk of breakthrough infections in vaccinated individuals at high risk of exposure such as healthcare personnel (HCP). A systematic literature review (SLR) applying the PRISMA declaration and the PECOS format using the following entry terms was used: "Health Personnel OR Healthcare Worker OR Healthcare Provider OR Healthcare Personnel AND breakthrough OR infection after vaccine*". The research was carried out utilizing the following databases: SCOPUS, PubMed, Embase, and Web of Sciences. An overall very low incidence of post-vaccination breakthrough infections was found, ranging from 0.011 to 0.001 (per 100 individuals at risk). Our findings further support the published high effectiveness rates of mRNA vaccines in preventing SARS-CoV-2 infections among fully vaccinated HCP. Additional studies are needed to define the duration of the vaccine-induced protection among HCP.

Indexed as

asymptomatic infectionBNT162b2COVID-19healthcare personnelmRNA-1273pandemicpost-vaccinationSARS-CoV-2TAK-919vaccination

Identifiers

PMID35051125
PMCPMC8781002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.